Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

Abstract

Over 30% of study participants in this group showed a positive response at the conclusion of the trial. This study suggested that DC-based cancer vaccines may provide an alternative therapy for prostate cancer patients whose disease no longer responds to hormone therapy.

References

Page 1

	Year	Citations
Cancer statistics, 1998 Sarah Landis, Thomas S. Murray, S. Bolden, CA A Cancer Journal for Clinicians American Cancer SocietyCancer StatisticsEpidemiologyCancer EpidemiologyMedicine	1998	2.4K
Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen G.P. Murphy, B.A. Tjoa, Haakon Ragde, The Prostate	1996	395
Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides B.A. Tjoa, S.J. Simmons, Victoria Bowes, The Prostate	1998	243
Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides B.A. Tjoa, Sheila J. Erickson, Victoria Bowes, The Prostate	1997	127
Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990. Jones Gw, Curtis Mettlin, Murphy Gp, PubMed	1995	80
Comparison of serum PSMA, PSA levels with results of cytogen-356 ProstaScint® scanning in prostatic cancer patients Gerald P. Murphy, Robert T. Maguire, Barbara Rogers, The Prostate Psa LevelsPrognostic BiomarkersUrologyProstatic Cancer PatientsGenitourinary Cancer	1997	57
In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy B.A. Tjoa, Sheila J. Erickson, Robert J. Barren, The Prostate	1995	51
Evaluation of PSA, free PSA, PSMA, and total and bone alkaline phosphatase levels compared to bone scans in the management of patients with metastatic prostate cancer Gerald P. Murphy, M.J. Troychak, Oliver E. Cobb, The Prostate	1997	20

Page 1